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Abstract
Successful gene therapy necessitates safe and efficient gene transfer. This article describes the use of a cationic polymer,
which was synthesized by cross-linking low molecular weight branched poly(ethylenimine) (PEI) with both b-cyclodextrin
and propane-1,2,3-triol, for efficient and safe non-viral gene delivery. Experimentation demonstrated that the polymer had a
pH buffering capacity and DNA condensing ability comparable to those of PEI 25 kDa. In B16-F0 cells, the polymer increased
the transfection efficiency of naked DNA by 700-fold and yielded better transfection efficiencies than Fugene HD (threefold
higher) and PEI 25 kDa (fivefold higher). The high transfection efficiency of the polymer was not affected by the presence of
serum during transfection. In addition to B16-F0 cells, the polymer enabled efficient transfection of HepG2 and U87 cells
with low cytotoxicity. Our results indicated that our polymer is a safe and efficient transfection reagent that warrants further
development for in vitro, in vivo and clinical applications.
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Introduction
Gene delivery by viral and non-viral vectors is an important
area of research due to its potential applications in gene therapy.
Though viral vectors generally have higher transfection efficiency,
their immunogenicity and safety risks make them an unfavorable
choice for clinical applications. Over the years, numerous non-
viral gene delivery systems have been reported [1–4]. Among these
systems, poly(ethylenimine) (PEI) has gained special attention
because of its high transfection efficiency [2]. PEI is a polyamine
which possesses a high proton buffering capacity over a wide pH
range [5]. Compared with its linear counterpart, branched PEI
(bPEI) has higher primary amine content. As primary amines
generally are more reactive than secondary amines, bPEI is easier
to modify [6] and has thus been favored over linear PEI in gene
delivery research [2]. In fact, as early as the 1990’s, bPEI 25 kDa
had already been exploited as a gene carrier [7]. The polymer and
its derivatives also emerged as favorites for delivering various
nucleic materials (such as ribozymes [8], plasmids [9] and
oligonucleotides [10]) for animal studies. Though bPEI 25 kDa
exhibited high transfection efficiency, its toxicity was also high.
The latter observation was supported by the 8.6% mortality rate in
mice 24 hours after nasal instillation of bPEI 25 kDa [11]. Such
high toxicity has impeded the practical application of bPEI
25 kDa.
To reduce toxicity, low molecular weight (LMW) bPEI has been
exploited as an alternative gene carrier [12]. Though LMW bPEI
exhibited lower toxicity, its transfection efficiency was measurably
inferior to that obtained with high molecular weight bPEI [13].
This result had been demonstrated by an earlier study [13], which
found that in human endothelial cell-derived EA.hy 926 cells, PEI
with a molecular weight of 70 kDa yielded an average transfection
efficiency of approximately 20–30%, whereas PEI with a
molecular weight less than or equal to 1.8 kDa produced little
or no transfection. In this study, we linked LMW bPEI first with
propane-1,2,3-triol, which functions as a biodegradable linker
generating a biodegradable, higher molecular weight construct of
PEI. The product was further cross-linked with b-cyclodextrin (b-
CD) to form a nanopolymer with a star-shaped architecture. That
nanopolymer was designated as b-CD-bPEI-propane-1,2,3-triol
(BPEA). The transfection efficiency of BPEA was not only
comparable, or even superior, to that obtained using bPEI
25 kDa or Fugene HD in various tumor cell lines, but also
produced little or no toxicity. Our results indicate that BPEA is a
novel nanopolymer that warrants further development as a gene
carrier for both in vitro and in vivo transfection.
Materials and Methods
Materials
Chemicals. bPEI (Mw=1.2 and 25 kDa), b-cyclodextrin,
dimethyl sulfoxide (DMSO), triethylamine (Et3N), propane-1,2,3-
triol, and 1,19-carbonyldiimidazole (CDI) were purchased from
Sigma–Aldrich (St. Louis, MO, USA). bPEI 25 kDa was purified
by dialysis against triple distilled water, then lyophilized before use.
Plasmids. The plasmid pEGFP-N1 and the pGL3 Luciferase
reporter vector were purchased from BD Biosciences (San Jose,
CA) and Promega Corporation (Madison, WI), respectively. They
were transformed into competent DH5a cells, and plated onto LB
plates supplemented with 100 mg/mL ampicillin. Plasmids were
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then isolated using the PureLink Hipure Plasmid Maxiprep kit
(Invitrogen) according to the manufacturer’s guidelines. The
quality and quantity of the purified plasmids were analyzed by
measuring their optical densities at 260 and 280 nm.
Cell culture. Dulbecco’s Modified Eagle’s Medium
(DMEM), Minimum Essential Medium (MEM), trypsin–EDTA
(0.25% trypsin–EDTA), penicillin–streptomycin (10,000 units
penicillin and 10 mg streptomycin/ml) and fetal bovine serum
(FBS) were obtained from Invitrogen. Human glioblastoma U87
cells, murine melanoma B16 cells and human hepatocellular liver
carcinoma HepG2 cells were purchased from ATCC (American
Type Culture Collection).
Animals. Normal female C57/BL6 mice were purchased
from Daehan Laboratory Animal Research Center (Korea). All
animal works were conducted in accordance with the protocol
approved by the Animal Care and Use Committee of Yonsei
Medical Center, Seoul, Korea.
Methods
Synthesis of BPEA. Propane-1,2,3-triol was dissolved in
degassed DMSO at a concentration of 0.17 g/ml and mixed with
a DMSO solution (0.3 g/ml) of CDI. Et3N was added to the
reaction mixture at a concentration of 33 ml/ml. The reaction was
conducted in the dark for 3 hours under an inert nitrogen
atmosphere. The reaction mixture was then diluted with 5 ml of
degassed DMSO, followed by an addition of a DMSO solution
(0.88 g/ml) of bPEI 1.2 kDa. The reaction was carried out for
16 hours in the dark at 37uC under an inert nitrogen atmosphere.
The crude reaction mixture was dialyzed against triple distilled
water at 4uC for 3 days with a molecular weight cutoff of 2 kDa.
The solution was then filtered using syringe filters and lyophilized
for 2 days to obtain bPEI-propane-1,2,3-triol (PEA).
To synthesize BPEA, b-CD and CDI were first mixed at a 1:1
ratio. The mixture was then dissolved in degassed DMSO at a
concentration of 0.2 g/ml. Et3N was added to the reaction
mixture at a concentration of 33 ml/ml. The reaction was carried
out for 3 hours in the dark under an inert nitrogen atmosphere.
Afterwards, 14 ml of a DMSO solution of PEA were added
dropwise into the reaction mixture. The reaction was carried out
for 16 hours and was performed in the dark at 37uC under an
inert nitrogen atmosphere. The crude reaction mixture was
dialyzed against triple distilled water at 4uC for 3 days with a
Figure 1. Synthesis and putative structure of BPEA.
doi:10.1371/journal.pone.0100258.g001
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molecular weight cutoff of 12.4 kDa. The solution was then
filtered by syringe filters. BPEA was obtained after lyophilization
for 2 days.
Proton nuclear magnetic resonance (1H-NMR). 20 mg of
BPEA, PEA or PEI was solubilized in 0.7 ml of deuterium oxide
(D2O).
1H-NMR spectra was recorded on an NMR spectrometer
(500 MHz; Bruker Corporation, Germany).
Fourier-transform infrared (FT-IR) spectroscopy. FT-
IR spectroscopy was performed using an FT-IR spectrometer
(Spectrum 2000, PERKIN ELMER) at ambient conditions. The
potassium bromide (KBr) disk technique was used for analysis.
Spectra were obtained at a resolution of 2 cm21, and reported as
an average of 16 scans.
Matrix-assisted laser desorption-ionization time-of-flight
(MALDI-TOF) mass spectrometry. The matrix solution was
prepared by dissolving 10 mg of the matrix (2,5-dihydroxybenzoic
acid/fucose = 1:1) in 1 ml of 1:1 water/acetonitrile mixture. This
solution was then mixed with an aqueous solution of a sample
(0.5 mg/ml) in a 1:1 ratio before analysis. MALDI-TOF mass
spectrometry was performed using a Voyager Biospectrometry
Workstation mass spectrometer (Applied Biosystems, Foster City,
CA, USA), equipped with a pulsed N2 laser (l=337 nm, 2 ns
pulse width) and operated in the linear delayed-extraction mode.
The acceleration voltage adopted was 22 kV.
Polyplex formation and electron microscopy. BPEA/
DNA polyplexes were prepared by adding polymer solution (in
triple distilled water) to an equivalent volume of plasmid solution
(in Tris/EDTA buffer) at an appropriate BPEA/DNA mass-to-
mass ratio. The mixture was vortexed gently for 10 seconds,
followed by incubation at room temperature for 30 minutes.
The surface morphologies of BPEA/DNA polyplexes were
characterized using both scanning electron microscopy (SEM) and
transmission electron microscopy (TEM). In brief, ten microliters
of a polyplex solution were dried onto a Joel specimen copper
support. The polyplexes were imaged on a LaB6 Joel CX120 II
with ASID scanning attachment at 20 kV. Apart from this, a drop
of the polyplex solution containing 0.1 wt% phosphotungstic acid
(PTA) was placed on a 200-mesh carbon-coated copper grid. After
evaporation of the solvent at ambient conditions for 5 min, images
were taken using a transmission electron microscope (JEM-2010
TEM) operating at an acceleration voltage of 100 kV.
Particle size and zeta potential measurement. The size
and surface charge of the formed polyplexes were examined by
laser-light scattering (Zetasizer 3000, Malvern Instruments, UK).
Data were reported as an average of 10 measurements.
Figure 2. 1H-NMR spectra of (A) bPEI 12 kDa, (B) PEA and (C) BPEA.
doi:10.1371/journal.pone.0100258.g002
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Gel retardation assay. The pDNA condensing ability of the
polymer of interest was studied by the gel retardation assay. After
the formation of polyplexes, the polyplexes were mixed with the
loading buffer, stained with Loading STAR (DYNE Bio,
Seongnam, Korea), and electrophoresed in a 1% agarose gel at
80 V for one hour.
pH buffering capacity assay. The pH buffering capacities
of BPEA and bPEI 25 kDa were evaluated as previously described
[14].
In vitro transfection efficiency assay. Different cancer cell
lines (U87, B16 and HepG2) were seeded separately in 24-well
plates at a density of 16105 cells per well, and incubated at 37uC
for 24 hours. During transfection, the growth medium was
replaced with 300 ml of fresh medium with or without 10% FBS.
Preparation of the polyplexes of BPEA/pGL3 or BPEA/pEGFP-
N1 was performed by mixing 2 mg of the plasmid with an
appropriate quantity of BPEA at appropriate BPEA/DNA mass-
to-mass ratios. The mixture was vortexed gently for 10 seconds,
followed by incubation at room temperature for 30 minutes.
Triple distilled water was then added volumetrically to the mixture
to reach a final volume of 100 ml. The mixture was added to each
well. After 5-hour incubation at 37uC, the transfection medium
was replaced with fresh growth medium. The cells were incubated
at 37uC for an additional 24 hours.
During experiments, Fugene HD and bPEI 25 kDa were used
as positive controls. The transfection efficiency of BPEA was
determined by the luciferase activity assay as previously described
[14]. Microscopic evaluation of EGFP expression in transfected
cells was also performed according to a previously published
method [15]. To perform flow cytometry analysis, the transfected
cells were trypsinized and re-suspended in PBS. Fluorescence-
activated cell sorting (FACS) of EGFP-positive cells was conducted
Figure 3. FT-IR spectra of (A) bPEI 12 kDa, (B) PEA and (C) BPEA.
doi:10.1371/journal.pone.0100258.g003
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Figure 4. MALDI-TOF mass spectra of (A) PEA and (B) BPEA.
doi:10.1371/journal.pone.0100258.g004
Figure 5. Polyplex formation of BPEA with DNA. (A) Schematic representation of the formation of BPEA/DNA polyplexes via electrostatic
interactions between BPEA and plasmid DNA. (B) A representative scanning electron micrograph and (C) transmission electron micrograph of the
polyplexes formed by BPEA at the polymer/DNA ratio of 60.
doi:10.1371/journal.pone.0100258.g005
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using a flow cytometer (Epics XL; Coulter, Hialeah, FL). Non-
transfected cells were adopted to set the background.
Cytotoxicity assay. Different cancer cell lines (U87, B16 and
HepG2) were seeded separately in 96-well plates at an initial
density of 5,000 cells per well, and incubated at 37uC for 24 hours.
The growth medium was replaced with 100 ml of fresh cell culture
medium with or without 10% FBS. 10 ml of the polymer solution
was added to each well. After 5-hour incubation at 37uC, the
polymer containing medium was replaced with 100 ml of fresh
growth medium. The cytotoxicity of the polymer was evaluated
using the Cell Count Kit-8 (CCK-8) according to the manufac-
turer’s guidelines. Cell viability (%) in each well was determined by
dividing the absorbance value (A450) of the test well by the A450
value of the control well, followed by a multiplication of the
quotient by 100.
Blood collection and hemolysis assay. Blood from anes-
thetized mice via cardiac puncture was collected into a heparin-
containing tube, and centrifuged for 10 minutes at 2,000 g at 4uC.
The collected erythrocytes were washed with PBS (pH=7.4) until
the supernatant was colorless. Polyplexes of BPEA and PEI
25 kDa, at various polymer/DNA ratios, were freshly prepared in
PBS before use. The collected erythrocytes were added to reach a
final concentration of 8% (v/v). After incubation at 37uC for one
hour, the mixture was centrifuged at 2,000 g for 15 minutes. The
absorbance of the supernatant was recorded at 414 nm. Exper-
iments were performed in triplicate. The extent of hemolysis in
PBS and 0.1% Triton X-100 was defined as 0% and 100%,
respectively.
Results
Fabrication and characterization of BPEA
Synthesis of PEA and BPEA. The procedure for synthesizing
BPEA is shown in Fig. 1. The synthetic procedure consisted of two
stages. In the first stage, the hydroxyl groups of propane-1,2,3-triol
were activated by CDI. Active imidazolyl carbamate intermediates
were formed and subsequently attacked by the primary amine
groups of PEI to generate PEA. In the second stage, CDI activated
the hydroxyl groups of b-CyD, which in turn reacted with the
primary amine groups of PEA to generate BPEA. Since the
molecular weight cutoff (12.4 kDa) of the dialysis membrane used
to isolate BPEA was much higher than the molecular weight of all
reactants used throughout the experiments, the dialysis process
affords the product in high purity.
NMR and FT-IR studies. According to Fig. 2, representative
signals of PEI (-CH2CH2N- protons) in D2O resonate between 2.5
and 3.2 ppm (Fig. 2A). The presence of peaks, which resonate
between 3.7 ppm and 4.1 ppm, from propane-1,2,3-triol (CH,
CH2) demonstrated the successful generation of PEA (Fig. 2B).
The NMR spectrum of BPEA is shown in Fig. 2C. The presence
of the representative signal at 4.95 ppm (C-1 hydrogen in b-CyD)
in the spectrum of BPEA suggested the successful incorporation of
b-CyD into PEA. The molar ratio of PEI to b-CyD to propane-
1,2,3-triol in BPEA was calculated based on the proton integral
values of the 1H NMR spectrum: 2.3–2.8 ppm (CH2 of PEI),
4.95 ppm (C-1 hydrogen in b-CyD) and 3.7–4.1 ppm (CH and
CH2 from propane-1,2,3-triol) and was approximated to be 5:1:6.
Figure 6. Physical characterization of BPEA and its polyplexes. (A) The diameters of the polyplexes measured by dynamic light scattering. (B)
The zeta potential of polyplexes formed by BPEA at different polymer/DNA ratios. (C) Gel retardation assay of PEI 25 kDa and BPEA. The polymer/DNA
ratios used in lanes 1, 2, 3, 4, 5, 6, 7 and 8 were 0, 0.03, 0.06, 0.125, 0.25, 0.5, 1 and 2, respectively. (D) The acid-base titration profiles of PEI 25 kDa and
BPEA. The solvent, 150 mM NaCl, was used as a control.
doi:10.1371/journal.pone.0100258.g006
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The successful generation of PEA and BPEA was further
confirmed using FT-IR. In the spectrum of PEI (Fig. 3A),
stretching vibration peaks of proton assigned to methyl and
methylene could be found at 2920 cm21 and 2822 cm21. After
cross-linking of PEI with propane-1,2,3-triol and due to the
hydrogen bonding between N-H of PEI and C=O of propane-
1,2,3-triol, an ester signal shifted to 1703 cm21 in the spectrum of
PEA (Fig. 3B). Finally, apart from the wide peak caused by the
OH group at around 3200–3400 cm21, O-C stretching vibration
peaks of b-CD appeared at 1032, 1083 and1153 cm21 in the
spectrum of BPEA (Fig. 3C), suggesting successful incorporation of
b-CD into PEA.
MALDI-TOF. BPEA and PEA were further characterized
using MALDI-TOF. Intensity signals for PEA were found
extensively in a range between 499.0 and 8253.6 (m/z), with the
highest peaks being found at around 706.9 (m/z) (Fig. 4A). On the
other hand, most of the intensity signals in the spectrum of BPEA
appeared from 513.6 to 19873.9 (m/z), with the highest peaks
being found at 1137.4 (m/z) (Fig. 4B). Due to the high
polydispersity of our polymers and the resulting mass discrimina-
tion against high-mass oligomers in the MALDI-TOF spectra
[16], the molecular weight distribution (MWD) of PEA and BPEA
can hardly be accurately determined using the results. However,
compared with the position of the peaks in the spectrum of PEA,
peaks in the spectrum of BPEA have been shifted towards the
higher mass range. Such a shift indicated that the molecular mass
of BPEA is higher than PEA, suggesting successful cross-linking of
PEA by b-CyD.
Physical characterization of BPEA. A schematic represen-
tation of the polyplex formation process between BPEA and DNA
plasmids was illustrated in Fig. 5A. It is expected that polyplexes
were formed via mainly electrostatic interactions. As shown by
SEM, the morphology of BPEA/DNA polyplexes was as compact
spheres (Fig. 5B). The particle size of BPEA polyplexes formed at
Figure 7. Gene transfection efficiency of BPEA/DNA polyplexes. (A) Fluorescence and differential interference contrast images of B16-F0,
HepG2 and U87 cells transfected with BPEA in the (a) absence and (b) presence of 10% FBS. (B) The fold of transfection efficiency obtained using
BPEA when the percentage of EGFP-positive (a and b) B16-F0, (c and d) HepG2 and (e and f) U87 cells transfected with BPEA, at different polymer/
DNA ratios, was compared with those achieved using Fugene HD, PEI 25 kDa and DNA alone, both in the (a, c and e) absence and (b, d and f)
presence of 10% FBS.
doi:10.1371/journal.pone.0100258.g007
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the optimal polymer/DNA ratio (60/1) was estimated by TEM to
be 283.3640.8 nm (Fig. 5C), with a unimodal size distribution
from 240 to 320 nm. This was consistent with the particle size
determined by dynamic light scattering (DLS), which found that at
a polymer/DNA ratio of 60/1, BPEA/DNA polyplexes had the
smallest particle size and had a Z-average diameter of approxi-
mately 270–330 nm (Fig. 6A).
In addition, the zeta potential of BPEA polyplexes was positive
at all N/P ratios tested (Fig. 6B). Results of the gel retardation
assay showed that BPEA can completely retard DNA at a
polymer/DNA ratio of 0.25/1, and such a DNA condensing
ability was comparable to that of PEI 25 kDa (Fig. 6C). As
determined by acid-base titration, the pH buffering capacity of
BPEA was comparable to that of bPEA 25 kDa (Fig. 6D).
In vitro transfection
Microscopic evaluation of EGFP expression.The fluorescence
and differential interference contrast images of B16-F0 cells
transfected with BPEA at different polymer/DNA ratios are
shown in Fig. 7A. The EGFP fluorescence yielded by BPEA-
mediated transfection was quantitatively assessed by flow cytom-
etry (Fig. 7B). The highest transfection efficiency obtained by
BPEA was 3-fold and 5-fold higher than that achieved by Fugene
HD and PEI 25 kDa, respectively (Fig. 7Ba). Compared with
using DNA alone, BPEA can increase the transfection efficiency
up to 700 fold (Fig. 7Ba). Such a high transfection efficiency was
maintained even in the presence of 10% FBS (Fig. 7Bb). Apart
from B16-F0 cells, the high transfection efficiency of BPEA was
confirmed in HepG2 and U87 cells. The flow cytometry results
showed that the highest transfection efficiency attained by BPEA
in these two cell lines was comparable to that of Fugene HD and
PEI 25 kDa, being far superior to that of the naked plasmid (Fig.
7Bc–f).
Luciferase activity assay. In addition to the EGFP trans-
fection efficiency assay, the transfection efficiency of BPEA was
assessed using a luciferase activity assay (Fig. 8). The results
showed that B16-F0 cells transfected with BPEA had 1–2 orders of
magnitude higher luciferase activity than those transfected with
Fugene HD and PEI 25 kDa and 4–5 orders of magnitude higher
than those transfected with DNA alone. In HepG2 and U87 cells,
the luciferase activity of the cells transfected with BPEA was also
close to that of the cells transfected with Fugene HD and PEI
25 kDa. The high transfection efficiency of BPEA was not
influenced by the presence of serum during transfection.
Cytotoxicity and hemolysis. The cytotoxicity of BPEA in
B16-F0, HepG2 and U87 cells in the absence and presence of 10%
FBS is shown in Fig. 9. The results suggested that, up to a
concentration of 200 mg/ml, BPEA was basically non-toxic to all
the cell lines tested. Comparatively, cells treated with PEI 25 kDa
displayed a drastic drop in their viability with increasing
concentrations of the polymer. The results of our hemolysis assay
(Fig. 10) also showed that PEI 25 kDa induced approximately 60–
80% hemolysis, which was approximately 2–4 times higher than
the extent of hemoglobin release induced by BPEA.
Discussion
Over the years, PEI has been widely exploited as a candidate
vector for gene delivery due to its high transfection efficiency;
however, its clinical practicality has been hampered by its high
toxicity during transfection. An earlier study has compared the
transfection efficiency of PEIs with different molecular weights
(600, 1200, 1800, 10,000, and 70,000 Da) in endothelial cells [13].
The study found that the transfection efficiency of PEI was
positively correlated with the molecular weight of PEI, and PEIs
with molecular weights below 1,800 Da essentially failed to
transfect cells. Given this fact, in this study we have cross-linked
LMW PEI with propane-1,2,3-triol via CDI-mediated coupling
reactions (Fig.1) to generate a biodegradable, higher molecular
weight construct of PEI, namely PEA. The rise in the molecular
weight after cross-linking is expected to augment the transfection
efficiency of the originally uncross-linked LMW PEI. But due to
the high biodegradability of propane-1,2,3-triol [17], the impact of
the increase in the molecular weight on cytotoxicity is minimal.
To further augment the efficiency in gene delivery, PEA was
cross-linked with b-cyclodextrin (b-CD) to generate a nanopoly-
mer with a star-shaped architecture. The viability of employing
cyclodextrins as linking agents to improve the performance of gene
carriers has been suggested by an earlier study, which linked PEI
with b-cyclodextrin and observed that the resulting product
induced an approximately four-fold increase in luciferase expres-
sion compared with that induced by unmodified PEI [18]. More
recently, a series of star polymers have been reported by Yang et
al., who conjugated multiple oligoethylenimine arms onto an a-
cyclodextrin core [19]. The star polymers showed high transfec-
tion efficiency in HEK293 and Cos7 cells, and had cytotoxicity
much lower than that of bPEI 25 kDa. Since current advances in
applications of cyclodextrins to non-viral gene delivery have been
Figure 8. Comparison of luciferase expression mediated by
BPEA (with different polymer/DNA ratios), PEI 25 kDa, Fugene
HD and DNA alone. The experiment was performed in (A) B16-F0, (B)
HepG2 and (C) U87 cells both in the absence and presence of 10% FBS.
doi:10.1371/journal.pone.0100258.g008
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reviewed by a recent article [4], readers are referred to that article
for details [4]. In general, cyclodextrins have high potential in gene
transfer because of their binding affinity to nucleic acids [20,21],
their ability to attenuate the cytotoxicity of other gene vectors [22],
and their absorption-enhancing property in therapeutics delivery
[23,24]. Given this fact, the performance of PEA in gene delivery
is expected to be augmented upon cross-linking with b-CD.
The structure of BPEA was characterized by NMR. The
presence of peaks resonating between 3.7 ppm and 4.1 ppm from
propane-1,2,3-triol (CH, CH2), 2.5 and 3.2 ppm from PEI
(-CH2CH2N- protons), and the representative signal at 4.95 ppm
from b-CD (C-1 hydrogen) demonstrated successful generation of
BPEA (Fig. 2). The success of BPEA formation was further
confirmed by the presence of the following three groups of signals
in the FT-IR spectrum of BPEA (Fig. 3): (a) an ester signal at
around 1700 cm-1, (b) O-C stretching vibration peaks of b-CD at
around 1030–1150 cm21, and (c) stretching vibration peaks of
methyl and methyne protons in PEI at around 2820–2920 cm21.
Moreover, as shown by the MALDI-TOF mass spectra of PEA
and BPEA, peaks in the spectrum of BPEA have been shifted
towards the higher mass range as compared with those in the
spectrum of PEA (Fig. 4). Such a shift indicated that the molecular
mass of BPEA is higher than PEA, suggesting successful cross-
linking of PEA by b-CyD.
The cytotoxicity of BPEA was determined by our cytotoxicity
test, which revealed that in all of the cell lines tested (i.e., U87,
HepG2 and B16-F0), BPEA had low cytotoxicity over a wide
range of concentrations (Fig. 9). The low cytotoxicity of BPEA
may be attributed to the low charge density of its polyplexes. As
suggested by a previous study, the cytotoxicity of PEI 25 kDa was
partially due to the membrane-disruptive property of the dense
cationic polymers [25]. This effect was supported by the
observation that at an N/P ratio of 10 or higher, the zeta
potential of polyplexes formed by PEI 25 kDa was usually higher
than +30 mV [26]. However, the zeta potential of polyplexes
formed by BPEA was less than +20 mV at all ratios tested (Fig. 6).
Such low charge density of the BPEA polyplexes may explain the
decreased disruption of the cell membrane, and hence the lower
cytotoxicity, when compared with PEI 25 kDa. The lower
membrane-disrupting activity of BPEA was confirmed by the
hemolysis assay (Fig. 10), which showed that BPEA induces a
much lower degree of hemoglobin release from mouse erythro-
cytes than does PEI 25 kDa.
With regards to polymeric gene delivery, one of the hurdles to
overcome is the cell membrane, which acts as a selective
permeable barrier to govern the transport of substances into and
out of the cell. Accordingly, the particle size of the polyplex
strongly influences the efficiency of its cellular uptake and the
resulting transfection efficiency. Our results showed that at a
polymer/DNA ratio of 60, the particle size of the polyplexes
formed by BPEA was approximately 250–350 nm (Fig. 6), which is
in the range for effective endocytosis. In addition, complexation of
Figure 9. The cytotoxicity of BPEA. The experiment was performed in (A and B) B16-F0, (C and D) HepG2 and (E and F) U87 cells both in the (A, C
and E) absence and (B, D and F) presence of 10% FBS. PEI 25 kDa was used as a positive control to compare the relative cytotoxicity of BPEA.
doi:10.1371/journal.pone.0100258.g009
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DNA with the cationic polymer (Fig. 5) will neutralize the negative
charge of the DNA molecule. As the polymer/DNA ratio
increases, the surface charge of the polyplex will increase gradually
[27,28]. A positive surface charge facilitates binding of the
polyplex to the anionic cell surfaces for cellular internalization
[29]. As the zeta potential of BPEA polyplexes was positive at all
polymer/DNA ratios tested, this characteristic may also partially
facilitate cellular internalization of the polyplexes. Once the
polyplexes have been internalized, they must then undergo endo-
lysosomal escape to avoid possible lysosomal degradation. Our
results showed that the pH buffering capacity of BPEA was
comparable to that of PEI 25 kDa, which has a high proton
buffering capacity over a broad range of pH values (Fig. 6). As
high buffering capacity has been associated with great proton
sponge effects, which can result in osmotic swelling and rupture of
endosomes, this suggests that polyplexes formed by BPEA may
efficiently disrupt the vesicle membrane to release the polyplexes
into cytoplasm.
The high transfection efficiency of BPEA was confirmed by the
EGFP transfection efficiency assay in B16-F0, HepG2 and U87
cells. As shown in Fig. 7A, the cells transfected with BPEA had
extensive EGFP expression. In order for a gene carrier to be
applicable in vivo or clinically, it must be compatible with serum.
The interactions of the cationic polymer and serum may thus be
used as a predictive model for in vivo transfection efficiency of the
polymer [30]. BPEA exhibited a high transfection efficiency even
in the presence of 10% FBS (Fig. 7). In B16-F0 cells, the
transfection efficiency obtained by BPEA in the presence of serum
was approximately 3-fold higher than that obtained by Fugene
HD and PEI 25 kDa, and 400-fold higher than that achieved by
naked DNA. Such a high transfection efficiency of BPEA was also
observed in HepG2 and U87, in which the transfection efficiency
of the polymer was comparable to, or even higher than, that
achieved by Fugene HD and PEI 25 kDa, and was further
confirmed by the luciferase activity assay (Fig. 8). This result shows
that BPEA is a polymer showing high efficiency in gene delivery to
a broad range of cell types, and the polymer has promising
applications for the future development of gene therapies for
different cancers.
Conclusions
BPEA is a cationic polymer synthesized for gene delivery. BPEA
has high pH buffering capacities and DNA condensation abilities,
and has low cytotoxicity over a wide range of working
concentrations. In addition, this polymer allows efficient transfec-
tion of various cancer cell lines, and this high transfection
efficiency persists in the presence of serum. In order to further
augment the performance, the detailed mechanisms of interaction
between plasmids and BPEA, as well as changes in structural
parameters of BPEA after complexation with DNA, are worth
elucidation in future research. This provides insights into proper
design and engineering of the polymeric vector. In addition, the
extent of cross-linking of PEI during synthesis of BPEA is worth
further optimization. The importance of this has been revealed by
earlier studies, which suggested that while cross-linking of PEI on
one hand could enhance the transfection efficiency [31,32], it
could also alter the pK profile of the PEI amines, reduce the
efficiency of endosomal release and ultimately have a negative
impact on transfection [33]. With further improvement and
optimization, it is envisaged that BPEA will emerge as an effective
gene carrier for in vitro and in vivo applications, as well as for future
cancer gene therapy.
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